EBS News and Press, Emergent Biosolutions Inc. From 06/27/23

2023-06-27 13:38:04 ET Emergent BioSolutions ( NYSE: EBS ) said Tuesday that president and chief executive officer Robert G. Kramer Sr. will retire and step down from his positions effective immediately. The company has named Haywood Miller as interim...

Robert G. Kramer Sr. to Retire Haywood Miller to Serve as Interim CEO GAITHERSBURG, Md., June 27, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS, “Emergent” or the “Company”) today announced that Robert G. Kramer Sr. has informed the Board of...

2023-06-26 05:30:00 ET Sometimes, a company hits a stumbling block -- or several of them. The stock plummets, and investors lose faith. But, in some cases, these down-on-their luck companies are able to turn things around. And if you spot signs of a bright future early enough, you can get i...

2023-06-09 08:20:00 ET Amid a slew of shareholder lawsuits, a Congressional investigation, insider-trading allegations, and negative press surrounding its improperly manufactured coronavirus vaccine, it shouldn't surprise anyone to hear that over the past three years, Emergent BioSolution...

2023-06-07 08:20:00 ET Shares of drug manufacturer Emergent BioSolutions (NYSE: EBS) are down 75% in the past 12 months. Investors have been turning to safer investments amid the bear market and ditching the risky drugmaker. But last quarter, the company's revenue came in higher tha...

2023-06-06 16:50:55 ET Summary Today, we put the spotlight on Chimerix, Inc. for the first time in 12 months. The company is advancing its primary oncology candidate in development, has a potentially large market, and sells for less than net cash on its balance sheet. An updat...

2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...

2023-05-15 18:27:50 ET Emergent BioSolutions (NYSE: EBS) has been quite the up-and-down stock of late. On Monday, it had an up session on the market, creeping northward by 1.2% and exceeding the S&P 500 's gain of 0.3%. Investors seemed to be expressing cautious optimism abo...

GAITHERSBURG, Md., May 15, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced it has completed the sale of its travel health business to Bavarian Nordic (OMX: BAVA). At closing Emergent received $270 million, subject to customary closing adjustments, and may receive up to ...

2023-05-11 14:12:03 ET Following a meeting of its expert advisors, the World Health Organization announced Thursday that the monkeypox outbreak would no longer be regarded as a public health emergency of international concern (PHEIC). Monkeypox virus, currently known as mpox, led to a g...